Royal Bank of Canada Portfolio holdings
Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$866M |
| 2 |
Toronto Dominion Bank
TD
|
+$774M |
| 3 |
Bank of Montreal
BMO
|
+$469M |
| 4 |
Amgen
AMGN
|
+$402M |
| 5 |
TC Energy
TRP
|
+$282M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$558M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$361M |
| 3 |
Philip Morris
PM
|
+$347M |
| 4 |
Workday
WDAY
|
+$335M |
| 5 |
iShares MSCI All Country Asia ex Japan ETF
AAXJ
|
+$333M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.3% |
| 2 | Technology | 11.83% |
| 3 | Healthcare | 8.85% |
| 4 | Energy | 7.86% |
| 5 | Industrials | 7.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NIU
7001
Niu Technologies
NIU
$166M
| $1K | ﹤0.01% |
150
| – | – |
|
7002
NextNav
NN
$3.29B
| $1K | ﹤0.01% |
276
-1,270
| -82% | -$6.1K |
|
7003
Neuropace
NPCE
$498M
| $1K | ﹤0.01% |
148
-288
| -66% | -$1.9K |
|
7004
NerdWallet
NRDS
$639M
| $1K | ﹤0.01% |
+144
| New | +$1.46K |
|
7005
Energy Vault
NRGV
$669M
| $1K | ﹤0.01% |
+142
| New | +$1.84K |
|
|
NUTX
7006
Nutex Health
NUTX
$1.28B
| $1K | ﹤0.01% |
+1
| New | +$1.18K |
|
|
NUVL
7007
DELISTED
Nuvalent
NUVL
| $1K | ﹤0.01% |
95
-1,030
| -92% | -$10.9K |
|
7008
NextCure
NXTC
$37.9M
| $1K | ﹤0.01% |
17
| – | – |
|
|
TEAD
7009
Teads Holding Co
TEAD
$63.6M
| $1K | ﹤0.01% |
224
-1,765
| -89% | -$13.3K |
|
|
ORBS
7010
Eightco Holdings
ORBS
$292M
| $1K | ﹤0.01% |
+1
| New | +$2.04K |
|
|
IMDX
7011
Insight Molecular Diagnostics
IMDX
$121M
| $1K | ﹤0.01% |
30
-202
| -87% | -$4.59K |
|
7012
Oportun Financial
OPRT
$351M
| $1K | ﹤0.01% |
156
-1,143
| -88% | -$13.2K |
|
7013
Outlook Therapeutics
OTLK
$166M
| $1K | ﹤0.01% |
34
-316
| -90% | -$9.09K |
|
7014
Passage Bio
PASG
$14.7M
| $1K | ﹤0.01% |
31
-89
| -74% | -$4.16K |
|
7015
PDS Biotechnology
PDSB
$13M
| $1K | ﹤0.01% |
250
-1,172
| -82% | -$5.57K |
|
7016
Phathom Pharmaceuticals
PHAT
$743M
| $1K | ﹤0.01% |
130
-1,114
| -90% | -$11.5K |
|
7017
P3 Health Partners
PIII
$36.5M
| $1K | ﹤0.01% |
3
-25
| -89% | -$6.96K |
|
7018
Pluri
PLUR
$17.9M
| $1K | ﹤0.01% |
125
| – | – |
|
7019
Praxis Precision Medicines
PRAX
$10.3B
| $1K | ﹤0.01% |
14
-122
| -90% | -$13K |
|
7020
ProShares Short QQQ
PSQ
$635M
| $1K | ﹤0.01% |
10
-80
| -89% | -$5.33K |
|
7021
PolyPid
PYPD
$91.7M
| $1K | ﹤0.01% |
8
-4
| -33% | -$599 |
|
7022
iShares MSCI Qatar ETF
QAT
$63.5M
| $1K | ﹤0.01% |
38
| – | – |
|
7023
Quantum Corp
QMCO
$973M
| $1K | ﹤0.01% |
25
-947
| -97% | -$35.9K |
|
7024
Quantum-Si Incorporated
QSI
$172M
| $1K | ﹤0.01% |
516
-58,656
| -99% | -$225K |
|
7025
Quad
QUAD
$506M
| $1K | ﹤0.01% |
196
-5,672
| -97% | -$27.4K |
|
Similar funds
Royal Bank of Canada's Q2 2022 Portfolio in Review
As of Q2 2022, Royal Bank of Canada held 8,274 positions worth $340B, down 15% from $400B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Royal Bank of Canada's Q2 2022 filing shows 398 new, 2,517 increased, 3,856 reduced and 651 closed positions. Its largest new stake was Aspen Technology Inc: 92,306 shares worth $17M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $558M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
- Royal Bank of Canada's largest Q2 2022 buy was Aspen Technology Inc: 92,306 shares worth $17M.
- Royal Bank of Canada added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $866M increase.
- Royal Bank of Canada's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $558M.
- Royal Bank of Canada fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $45.7M.
- Royal Bank of Canada's ten largest holdings make up 20% of its $340B portfolio in Q2 2022.
- Royal Bank of Canada opened 398 new positions and closed 651 in Q2 2022.
- Royal Bank of Canada's portfolio value fell 15% quarter-over-quarter to $340B.
Based on Royal Bank of Canada's 13F filing for Q2 2022, filed 15 Aug 2022.